Human genetic risk of treatment with antiviral nucleoside analog drugs that induce lethal mutagenesis: the special case of molnupiravir-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Human genetic risk of treatment with antiviral nucleoside analog drugs that induce lethal mutagenesis: the special case of molnupiravir

Published:2022-01 Issue:1 Volume:63 Page:37-63
ISSN:0893-6692
Container-title:Environmental and Molecular Mutagenesis
language:en
Short-container-title:Environ and Mol Mutagen

Author:

Waters Michael D.¹^ORCID,Warren Stafford²,Hughes Claude³,Lewis Philip⁴,Zhang Fengyu⁵

Affiliation:

1. Michael Waters Consulting USA Hillsborough North Carolina USA

2. Anne Arundel Medical Center Annapolis Maryland USA

3. Duke University Medical Center Durham North Carolina USA

4. Cornell University Ithaca New York USA

5. Global Clinical and Translational Research Institute Bethesda Maryland USA

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Genetics (clinical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/em.22471

Reference185 articles.

1. Mammalian cell gene mutation assays working group report

2. Antiviral drugs specific for coronaviruses in preclinical development

3. Small-Molecule Antiviral β- d - N 4 -Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance

4. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

5. Favipiravir: A new and emerging antiviral option in COVID-19

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spatio-temporal characteristics of genotoxicity in the Yangtze River under the background of COVID-19 pandemic;Frontiers of Environmental Science & Engineering;2024-09-13

2. Discovery of novel quinoline papain-like protease inhibitors for COVID-19 through topology constrained molecular generative model;2024-09-09

3. Antiviral therapy for COVID-19;COVID-19: An Update;2024-09-01

4. A review on recent advancements in pharmaceutical technology transfer of tablets from an Indian perspective;Annales Pharmaceutiques Françaises;2024-08

5. Evaluation of N4-hydroxycytidine incorporation into nucleic acids of SARS-CoV-2-infected host cells by direct measurement with liquid chromatography-mass spectrometry;Nucleosides, Nucleotides & Nucleic Acids;2024-05-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3